Metastatic Prostate Cancer
Showing 1 - 25 of >10,000
Metastatic Prostate Cancer in Pirkanmaa Hospital District in
Not yet recruiting
- Metastatic Castration Sensitive Prostate Cancer (mCSPC)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- abiraterone
- +10 more
- (no location specified)
Jan 17, 2023
Prostate Cancer Metastatic Trial (SABR, no RT)
Not yet recruiting
- Prostate Cancer Metastatic
- SABR
- no RT
- (no location specified)
Jul 11, 2022
Prostate Metastases Trial in Toronto (Radiotherapy)
Not yet recruiting
- Prostate Metastases
- Radiotherapy
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Dec 9, 2022
Novel Therapy Target in Metastatic Prostate Cancer
Not yet recruiting
- Prostate Neoplasms
- Tissue
- (no location specified)
Oct 10, 2022
Metastatic Prostate Cancer Trial in Cleveland (Exercise therapy)
Not yet recruiting
- Metastatic Prostate Cancer
- Exercise therapy
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Aug 2, 2022
Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Prostate Cancer Trial in San Antonio (High Intensity
Recruiting
- Prostate Cancer Metastatic
- +3 more
- High Intensity Interval Training
-
San Antonio, TexasUT Health San Antonio
Feb 17, 2022
Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)
Recruiting
- Prostate Cancer
- Metastatic Prostate Cancer
- Abiraterone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Feb 21, 2023
Metastatic Prostate Cancer, Neuroendocrine Prostate Cancer Trial in Detroit, New York, Lancaster (ORIC-944)
Recruiting
- Metastatic Prostate Cancer
- Neuroendocrine Prostate Cancer
-
Detroit, Michigan
- +2 more
Jun 15, 2022
Testing Circulating Tumour DNA for Homologous Recombination Gene
Not yet recruiting
- Circulating Tumor DNA
- Metastatic Prostate Cancer
- Blood sample
- Urine sample
-
Tours, FranceUniversity hospital
Jun 8, 2022
Metastatic Prostate Cancer Trial in New York (MR-Guided Prostate SBRT)
Recruiting
- Metastatic Prostate Cancer
- MR-Guided Prostate SBRT
-
New York, New YorkWeill Cornell Medicine
Oct 29, 2021
FTT PET/CT in Metastatic Prostate Cancer
Not yet recruiting
- Prostate Cancer Metastatic
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Jul 13, 2022
to DIrect the manaGement of Metastatic Prostate Cancer
Recruiting
- Metastatic Prostate Cancer
-
London, United KingdomUniversity College London Hospital
Jan 6, 2022
Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A
Not yet recruiting
- Metastatic Prostate Cancer
- +2 more
- Darolutamide
- +4 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 14, 2022
Prostate Cancer Trial in Toronto (Hyperpolarized Pyruvate (13C))
Recruiting
- Prostate Cancer
- Hyperpolarized Pyruvate (13C)
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
May 4, 2022
Genetic Testing for Men With Metastatic Prostate Cancer
Recruiting
- Metastatic Prostate Carcinoma
- +2 more
- Biospecimen Collection
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 9, 2022
Prostate Cancer, Prostate Cancer Metastatic Trial in Dallas (68Ga PSMA-11 injection, Positron Emission Tomography/Computed
Recruiting
- Prostate Cancer
- Prostate Cancer Metastatic
- 68Ga PSMA-11 injection
- Positron Emission Tomography/Computed Tomography
-
Dallas, TexasUT Southwestern Medical Center
Jan 21, 2022
Metastatic Prostate Cancer Trial in Toronto (GA+M Intervention, RSM intervention, GA+RSM intervention)
Not yet recruiting
- Metastatic Prostate Cancer
- GA+M Intervention
- +2 more
-
Toronto, Ontario, Canada
- +1 more
Oct 12, 2022
Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic
Not yet recruiting
- Metastatic Malignant Neoplasm in the Viscera
- +4 more
- Lutetium Lu 177 Dotatate
- (no location specified)
Jan 25, 2023
Metastatic Prostate Cancer Trial in Birmingham ([68Ga]PSMA-PET/MRI or PET/CT)
Completed
- Metastatic Prostate Cancer
- [68Ga]PSMA-PET/MRI or PET/CT
-
Birmingham, AlabamaUniversity of Alabama at Birmingham Medical Center
Mar 7, 2022
Predictive fActors for toleraNce to Taxane Based CHemotherapy In
Completed
- Elderly Patients
- Metastatic Prostate Cancer
- Taxane chemotherapy
-
Florence, ItalyAOU Careggi Radiation Oncology Unit
Jul 21, 2022
Circulating Tumor Cells in High Risk and Early Metastatic
Recruiting
- High Risk Prostate Carcinoma
- +3 more
- Blood collection
-
Bala-Cynwyd, Pennsylvania
- +1 more
Jun 28, 2022
Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)
Completed
- Prostate Cancer
- Cabozantinib
- Androgen Ablation Therapy
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 23, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Mexico City (SV-102)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Mexico City, MexicoHospital Diomed
Sep 14, 2022
Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)
Recruiting
- Metastatic Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
-
Boston, Massachusetts
- +1 more
Jul 18, 2022
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))
Enrolling by invitation
- Prostate Cancer
- +5 more
- 131I-PSMA-1095 Radioligand Therapy (RLT)
-
Montreal, Quebec, CanadaStephan Probst
Sep 20, 2021